Skip to main content

Animations

MJFF Publications

4651 - 4660 of 6466 Results
Title
Year
  • Year
  • 2016
  • 2025
  • 2017
  • 2020
  • 2020
  • 2025
  • 2025
  • 2022
  • 2016
  • 2022
  • Summary Details
    OPEN
    Title: Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1096/fj.201600816r
    Citation Count: 410
  • Summary Details
    OPEN
    Title: Seed amplification of MSA alpha-synuclein aggregates preserves the biological and structural properties of brain-derived aggregates
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41467-025-66146-4
    Citation Count: 8
  • Summary Details
    OPEN
    Title: A high-resolution map of the human small non-coding transcriptome
    Journal Name: Bioinformatics
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/bioinformatics/btx814
    Citation Count: 28
  • Summary Details
    OPEN
    Title: An application of generalized matrix learning vector quantization in neuroimaging
    Journal Name: Computer Methods and Programs in Biomedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.cmpb.2020.105708
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Co-Existence of tau and α-synuclein pathology in fetal graft tissue at autopsy: A case report
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.12.013
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Neurotherapeutic effects of Vutiglabridin as a Paraoxonase-2 modulator in preclinical models of Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-025-00896-z
    Citation Count: 1
  • Summary Details
    OPEN
    Title: It Is Personal: What People with Parkinson's Disease Say Matters Most for Quality of Life
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.70134
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Paper Spray Ionization Ion Mobility Mass Spectrometry of Sebum Classifies Biomarker Classes for the Diagnosis of Parkinson’s Disease
    Journal Name: JACS Au
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/jacsau.2c00300
    Citation Count: 47
  • Summary Details
    OPEN
    Title: Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid Hydroxylase
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.5b01780
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Reply to: “Age‐Adjusted Serum Neurofilament Predicts Cognitive Decline in Parkinson's Disease (MARK‐PD)”
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28920
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.